CHRNA1 Antikörper (AA 21-255)
-
- Target Alle CHRNA1 Antikörper anzeigen
- CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))
-
Bindungsspezifität
- AA 21-255
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHRNA1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Ratte
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Acetylcholine receptor subunit alpha protein (21-255AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CHRNA1 Primärantikörper
-
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (AA 25-240) antibody
CHRNA1 Reaktivität: Human ELISA, WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (AA 332-457) antibodyCHRNA1 Reaktivität: Maus, Ratte WB, IF Wirt: Maus Monoclonal 26-Acetylcholine Receptor alpha unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (C-Term) antibodyCHRNA1 Reaktivität: Human, Maus, Hund, Kaninchen, Meerschweinchen, Schwein WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (AA 21-255) antibodyCHRNA1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (C-Term) antibodyCHRNA1 Reaktivität: Human ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (AA 25-234) antibodyCHRNA1 Reaktivität: Torpedo californica ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (AA 21-230) antibodyCHRNA1 Reaktivität: Maus ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (Internal Region) antibodyCHRNA1 Reaktivität: Human, Maus, Ratte ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) antibodyCHRNA1 Reaktivität: Human IF Wirt: Kaninchen Polyclonal unconjugated
anti-Acetylcholine Receptor Subunit alpha (CHRNA1) (N-Term) antibodyCHRNA1 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Kaninchen, Meerschweinchen, Pferd, Affe, Fledermaus WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CHRNA1 (Acetylcholine Receptor Subunit alpha (CHRNA1))
- Andere Bezeichnung
- CHRNA1 (CHRNA1 Produkte)
- Synonyme
- CHRNA1 antikoerper, ACHRA antikoerper, ACHRD antikoerper, CHRNA antikoerper, CMS2A antikoerper, FCCMS antikoerper, SCCMS antikoerper, NACHRA1 antikoerper, AI385656 antikoerper, AI608266 antikoerper, Achr-1 antikoerper, Acra antikoerper, cholinergic receptor nicotinic alpha 1 subunit antikoerper, cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) antikoerper, CHRNA1 antikoerper, Chrna1 antikoerper
- Hintergrund
-
Background: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Aliases: Acetylcholine receptor subunit alpha antibody, ACHA_HUMAN antibody, AChR antibody, ACHRA antibody, ACHRD antibody, CHNRA antibody, Cholinergic receptor nicotinic alpha 1 subunit antibody, Cholinergic receptor nicotinic alpha polypeptide 1 antibody, Cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) antibody, Chrna1 antibody, CMS1A antibody, CMS1B antibody, CMS2A antibody, FCCMS antibody, Nicotinic cholinergic receptor alpha 1 antibody, SCCMS antibody, Schizophrenia neurophysiologic defect candidate antibody
- UniProt
- P02708
- Pathways
- Skeletal Muscle Fiber Development
-
